Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Effects of buprenorphine and methadone in methadone-maintained subjects.

Walsh SL, June HL, Schuh KJ, Preston KL, Bigelow GE, Stitzer ML.

Psychopharmacology (Berl). 1995 Jun;119(3):268-76.

PMID:
7675960
2.

Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence.

Orman JS, Keating GM.

Drugs. 2009;69(5):577-607. doi: 10.2165/00003495-200969050-00006. Review.

PMID:
19368419
3.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x.

PMID:
18503626
4.

Opioid dependence: rationale for and efficacy of existing and new treatments.

Fiellin DA, Friedland GH, Gourevitch MN.

Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S173-7. Review.

5.

Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.

Mannelli P, Peindl KS, Lee T, Bhatia KS, Wu LT.

Curr Drug Abuse Rev. 2012 Mar;5(1):52-63. Review.

6.

Current pharmacotherapies for opioid dependence.

Kosten TR.

Psychopharmacol Bull. 1990;26(1):69-74. Review.

PMID:
2196628
7.

Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development.

Konijnenberg C, Melinder A.

Child Neuropsychol. 2011;17(5):495-519. doi: 10.1080/09297049.2011.553591. Review.

PMID:
21480011
8.
9.

Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence.

Compton PA, Ling W, Charuvastra VC, Wesson DR.

J Addict Dis. 1995;14(3):97-114. Review.

PMID:
8555282
10.

Methadone maintenance treatment.

Senay EC.

Int J Addict. 1985 Jun-Jul;20(6-7):803-21. Review.

PMID:
3908338
11.

Assessment of buprenorphine in a drug discrimination procedure in humans.

Bigelow GE, Preston KL.

NIDA Res Monogr. 1992;121:28-37. Review.

PMID:
1406908
12.

Use of drug combinations in treatment of opioid withdrawal.

Stine SM, Kosten TR.

J Clin Psychopharmacol. 1992 Jun;12(3):203-9. Review.

PMID:
1629388
13.

Benzodiazepines, methadone and buprenorphine: interactions and clinical management.

Lintzeris N, Nielsen S.

Am J Addict. 2010 Jan-Feb;19(1):59-72. doi: 10.1111/j.1521-0391.2009.00007.x. Review.

PMID:
20132123
14.

Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?

McCarthy JJ.

J Matern Fetal Neonatal Med. 2012 Feb;25(2):109-12. doi: 10.3109/14767058.2011.600371. Review.

PMID:
21867403
15.

Drug abstinence effects: opioids.

Preston KL.

Br J Addict. 1991 Dec;86(12):1641-6. Review.

PMID:
1786495
16.

Detoxification after methadone maintenance treatment.

Cushman P Jr.

Ann N Y Acad Sci. 1981;362:217-30. Review. No abstract available.

PMID:
7020531
17.
Items per page

Supplemental Content

Support Center